INO80B, INO80 complex subunit B, 83444

N. diseases: 11; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0041296
Disease: Tuberculosis
Tuberculosis
0.020 AlteredExpression disease BEFREE Furthermore, the existence of five hypermethylated candidate genes (esxC, fabG3, fbpB, papA1 and pks2) in PAS-resistant M. tuberculosis H37Rv was verified using protein-protein interaction analysis in the STRING database. 31562690 2020
CUI: C0020175
Disease: Hunger
Hunger
0.020 Biomarker phenotype BEFREE The other three IES-2 subscales showed a few small positive and negative correlations with food intake, including small positive associations of diet quality scores in women, but not men, with eating for physical rather than emotional reasons and reliance on hunger and satiety cues. 30584896 2019
CUI: C0020175
Disease: Hunger
Hunger
0.020 GeneticVariation phenotype BEFREE The best solution from the principal factors analysis of the 23 items of the IES-2 revealed four factors corresponding to the four subscales (F1: Eating for physical rather than emotional reasons; F2: Unconditional permission to eat; F3: Reliance on hunger and satiety cues; F4: Body-food choice congruence), as reported by the authors of the questionnaire. 28432008 2017
CUI: C0041296
Disease: Tuberculosis
Tuberculosis
0.020 GeneticVariation disease BEFREE A rough M. tuberculosis H37Rv ΔpapA1 sulfoglycolipid-deficient mutant had significantly diminished Congo Red uptake though hexadecane-aqueous buffer partitioning was similar to H37Rv. 28465507 2017
CUI: C0085207
Disease: Gestational Diabetes
Gestational Diabetes
0.010 Biomarker phenotype BEFREE After adjusting for confounding variables, the cross-sectional analyses showed that the two subscales of IES-2 at the first GDM visit were associated with lower weight and BMI before pregnancy, and lower weight at the first GDM visit (β = -0.181 to -0.215, all p ≤ 0.008). 31154153 2019
CUI: C0855228
Disease: Eating disorder symptom
Eating disorder symptom
0.010 AlteredExpression phenotype BEFREE The current study examined the psychometric properties of the Intuitive Eating Scale-2 (IES-2) in a Hispanic American sample of adult college students (N=482), and related IES-2 scores to levels of disordered eating, body mass index (BMI), fruit and vegetable consumption, and body shape satisfaction. 29156372 2018
CUI: C0242379
Disease: Malignant neoplasm of lung
Malignant neoplasm of lung
0.010 Biomarker disease BEFREE Further, its expression, as well as that of another subunit Ino80B, negatively correlates with disease prognosis in lung cancer patients. 27641337 2017
CUI: C0684249
Disease: Carcinoma of lung
Carcinoma of lung
0.010 Biomarker disease BEFREE Further, its expression, as well as that of another subunit Ino80B, negatively correlates with disease prognosis in lung cancer patients. 27641337 2017
CUI: C1306460
Disease: Primary malignant neoplasm of lung
Primary malignant neoplasm of lung
0.010 Biomarker disease BEFREE Further, its expression, as well as that of another subunit Ino80B, negatively correlates with disease prognosis in lung cancer patients. 27641337 2017
CUI: C1561826
Disease: Overweight and obesity
Overweight and obesity
0.010 Biomarker disease BEFREE For group differences, the results were as hypothesized: men had higher IES-2 scores than women, and participants with under- and average weight showed higher IES-2 scores than participants with overweight and obesity. 28645751 2017
CUI: C0013537
Disease: Eclampsia
Eclampsia
0.010 GeneticVariation disease BEFREE Mutation screening of the candidate genes (n = 13) rapidly reduced the minimal critical region and showed the INO80B gene, encoding a novel winged helix domain (pfam14465) and part of the chromatin-remodeling complex, to be linked to pre-eclampsia. 25143393 2015
CUI: C0376358
Disease: Malignant neoplasm of prostate
Malignant neoplasm of prostate
0.010 Biomarker disease BEFREE These studies suggest that the growth-promoting role of IGFBP-2 in prostate cancer is inhibited by its intracellular interaction with PAPA-1. 19095771 2009
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.010 Biomarker disease BEFREE These studies suggest that the growth-promoting role of IGFBP-2 in prostate cancer is inhibited by its intracellular interaction with PAPA-1. 19095771 2009